Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Shinohara, Ayaka*; Hanaoka, Hirofumi*; Sakashita, Tetsuya*; Sato, Tatsuhiko; Yamaguchi, Aiko*; Ishioka, Noriko*; Tsushima, Yoshito*
Annals of Nuclear Medicine, 32(2), p.114 - 122, 2018/02
Times Cited Count:8 Percentile:40.13(Radiology, Nuclear Medicine & Medical Imaging)Radionuclide therapy with low-energy auger electron emitters could potentially provide high anti-tumor efficacy while keeping normal organs toxicity low. In this study, we evaluated the usefulness of auger electron emitter I and compared it with beta-emitter
I for tumor treatment in 2D and 3D cell culture models. The computer simulation model for 2D and 3D cell culture were constructed, and the absorbed radiation dose of
I or
I in each model were calculated by using a Monte Carlo simulation code (PHITS). The therapeutic effect of
I was comparable to that of
I in 2D model, but the efficacy was inferior to that of
I-MIBG in 3D model, since crossfire effect is negligible and the homogeneous distribution of radionuclide was insufficient.
Sasaki, Ichiro; Watanabe, Shigeki; Ohshima, Yasuhiro; Sugo, Yumi; Yamada, Keiichi*; Hanaoka, Hirofumi*; Ishioka, Noriko
Peptide Science 2015, p.243 - 246, 2016/03
Hanaoka, Hirofumi*; Ohshima, Yasuhiro; Suzuki, Yurika*; Yamaguchi, Aiko*; Watanabe, Shigeki; Uehara, Tomoya*; Nagamori, Shushi*; Kanai, Yoshikatsu*; Ishioka, Noriko; Tsushima, Yoshito*; et al.
Journal of Nuclear Medicine, 56(5), p.791 - 797, 2015/05
Times Cited Count:19 Percentile:62.22(Radiology, Nuclear Medicine & Medical Imaging)Sasaki, Ichiro; Hanaoka, Hirofumi*; Yamada, Keiichi*; Watanabe, Shigeki; Sugo, Yumi; Ohshima, Yasuhiro; Suzuki, Hiroyuki; Ishioka, Noriko
Peptide Science 2014, p.257 - 260, 2015/03
Watanabe, Satoshi; Hashimoto, Kazuyuki; Watanabe, Shigeki; Iida, Yasuhiko*; Hanaoka, Hirofumi*; Endo, Keigo*; Ishioka, Noriko
Journal of Radioanalytical and Nuclear Chemistry, 303(1), p.935 - 940, 2015/01
Times Cited Count:15 Percentile:73.03(Chemistry, Analytical)Sasaki, Ichiro; Yamada, Keiichi*; Watanabe, Shigeki; Hanaoka, Hirofumi*; Sugo, Yumi; Oku, Hiroyuki*; Ishioka, Noriko
JAEA-Review 2013-059, JAEA Takasaki Annual Report 2012, P. 96, 2014/03
Ohshima, Yasuhiro; Hanaoka, Hirofumi*; Tominaga, Hideyuki*; Kanai, Yoshikatsu*; Kaira, Kyoichi*; Yamaguchi, Aiko*; Nagamori, Shushi*; Oriuchi, Noboru*; Tsushima, Yoshito*; Endo, Keigo*; et al.
Annals of Nuclear Medicine, 27(4), p.314 - 324, 2013/05
Times Cited Count:16 Percentile:50.60(Radiology, Nuclear Medicine & Medical Imaging)Sasaki, Ichiro; Yamada, Keiichi*; Watanabe, Shigeki; Hanaoka, Hirofumi*; Sugo, Yumi; Oku, Hiroyuki*; Ishioka, Noriko
Peptide Science 2013, p.157 - 160, 2013/03
Watanabe, Shigeki; Yamada, Keiichi*; Tsukui, Narutaka*; Hanaoka, Hirofumi*; Ohshima, Yasuhiro; Yamaguchi, Aiko*; Oku, Hiroyuki*; Ishioka, Noriko
JAEA-Review 2012-046, JAEA Takasaki Annual Report 2011, P. 88, 2013/01
Hanaoka, Hirofumi*; Watanabe, Shigeki; Tominaga, Hideyuki*; Ohshima, Yasuhiro; Watanabe, Satoshi; Yamada, Keiichi*; Iida, Yasuhiko*; Ishioka, Noriko; Endo, Keigo*
JAEA-Review 2012-046, JAEA Takasaki Annual Report 2011, P. 89, 2013/01
no abstracts in English
Achmad, A.*; Hanaoka, Hirofumi*; Yoshioka, Hiroki*; Yamamoto, Shinji*; Tominaga, Hideyuki*; Araki, Takuya*; Ohshima, Yasuhiro; Oriuchi, Noboru*; Endo, Keigo*
Cancer Science, 103(3), p.600 - 605, 2012/03
Times Cited Count:27 Percentile:57.12(Oncology)Watanabe, Satoshi; Watanabe, Shigeki; Iida, Yasuhiko*; Hanaoka, Hirofumi*; Endo, Keigo*; Ishioka, Noriko
JAEA-Review 2011-043, JAEA Takasaki Annual Report 2010, P. 92, 2012/01
no abstracts in English
Ohshima, Yasuhiro; Hanaoka, Hirofumi*; Watanabe, Shigeki; Sugo, Yumi; Watanabe, Satoshi; Tominaga, Hideyuki*; Oriuchi, Noboru*; Endo, Keigo*; Ishioka, Noriko
JAEA-Review 2011-043, JAEA Takasaki Annual Report 2010, P. 91, 2012/01
Ohshima, Yasuhiro; Hanaoka, Hirofumi*; Watanabe, Shigeki; Sugo, Yumi; Watanabe, Satoshi; Tominaga, Hideyuki*; Oriuchi, Noboru*; Endo, Keigo*; Ishioka, Noriko
Nuclear Medicine and Biology, 38(6), p.857 - 865, 2011/08
Times Cited Count:14 Percentile:46.20(Radiology, Nuclear Medicine & Medical Imaging)Ishioka, Noriko; Watanabe, Shigeki; Hanaoka, Hirofumi*
Naibumpitsu Gazo Kensa, Shindan Manyuaru, p.218 - 219, 2011/04
no abstracts in English
Paudyal, P.*; Paudyal, B.*; Hanaoka, Hirofumi*; Oriuchi, Noboru*; Iida, Yasuhiko*; Yoshioka, Hiroki*; Tominaga, Hideyuki*; Watanabe, Satoshi; Watanabe, Shigeki; Ishioka, Noriko; et al.
JAEA-Review 2010-065, JAEA Takasaki Annual Report 2009, P. 108, 2011/01
Watanabe, Satoshi; Hashimoto, Kazuyuki; Hanaoka, Hirofumi*; Endo, Keigo*; Ishioka, Noriko
JAEA-Review 2010-065, JAEA Takasaki Annual Report 2009, P. 109, 2011/01
no abstracts in English
Watanabe, Shigeki; Hanaoka, Hirofumi*; Liang, J. X.*; Iida, Yasuhiko*; Watanabe, Satoshi; Endo, Keigo*; Ishioka, Noriko
JAEA-Review 2010-065, JAEA Takasaki Annual Report 2009, P. 107, 2011/01
Watanabe, Shigeki; Hanaoka, Hirofumi*; Liang, J. X.; Iida, Yasuhiko*; Endo, Keigo*; Ishioka, Noriko
Journal of Nuclear Medicine, 51(9), p.1472 - 1479, 2010/09
Times Cited Count:22 Percentile:57.15(Radiology, Nuclear Medicine & Medical Imaging)Paudyal, P.*; Paudyal, B.*; Hanaoka, Hirofumi*; Oriuchi, Noboru*; Iida, Yasuhiko*; Yoshioka, Hiroki*; Tominaga, Hideyuki*; Watanabe, Satoshi; Watanabe, Shigeki; Ishioka, Noriko; et al.
Cancer Science, 101(4), p.1045 - 1050, 2010/04
Times Cited Count:40 Percentile:67.16(Oncology)